Tectonic Therapeutic (NASDAQ:TECX – Get Free Report)’s share price gapped up before the market opened on Wednesday . The stock had previously closed at $16.65, but opened at $17.36. Tectonic Therapeutic shares last traded at $17.19, with a volume of 511 shares trading hands.
Analyst Ratings Changes
Several equities analysts have recently weighed in on the stock. TD Cowen initiated coverage on shares of Tectonic Therapeutic in a research note on Monday, June 24th. They issued a “buy” rating on the stock. Piper Sandler began coverage on shares of Tectonic Therapeutic in a report on Wednesday, June 26th. They set an “overweight” rating and a $76.00 target price for the company.
Check Out Our Latest Stock Report on Tectonic Therapeutic
Tectonic Therapeutic Stock Down 0.3 %
Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) last issued its quarterly earnings results on Thursday, May 9th. The company reported ($0.15) EPS for the quarter. On average, equities analysts predict that Tectonic Therapeutic will post -5 EPS for the current year.
About Tectonic Therapeutic
Avrobio, Inc is a bio-technology company. It develops step-change cell and gene therapies for the treatment of cancer and rare disease. The company operates primarily in the United States and Canada. Avrobio, Inc is based in MA, United States.
Further Reading
- Five stocks we like better than Tectonic Therapeutic
- What is Short Interest? How to Use It
- Real Estate Stock Signals a Boom in Manufacturing Activity
- How Technical Indicators Can Help You Find Oversold StocksĀ
- This Medical Giant’s Stock Rebounds: A 15% Upside Is the Minimum
- Insider Trading – What You Need to Know
- Financial Giant’s Shares Soar on EPS Beat and Record Asset Levels
Receive News & Ratings for Tectonic Therapeutic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tectonic Therapeutic and related companies with MarketBeat.com's FREE daily email newsletter.